FEMSelect, a company developing EnPlace, a minimally invasive and meshless device for women with pelvic floor issues, raises $9M in Series B funding with participation from Mid Atlantic Bio Angels.

Link to article: https://www.prnewswire.com/news-releases/womens-health-leader-femselect-secures-us9m-series-b-financing-301652846.html